Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin

Oral Oncology

Volumn 39, Issue 2, 2003, Pages 157-162

  Miyashita, Hitoshi ^a   Nitta, Yasutaka ^a   Mori, Shiro ^a   Kanzaki, Atsuko ^a   Nakayama, Kentaro ^a   Terada, Kunihiko ^b   Sugiyama, Toshihiro ^b   Kawamura, Hiroshi ^a   Sato, Atsushi ^c   Morikawa, Hidehiro ^a   Motegi, Katutoshi ^a   Takebayashi, Yuji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

ATP7B; Cisplatin; Drug resistance; Oral squamous cell carcinoma

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BIOLOGICAL MARKER; CARRIER PROTEIN; CISPLATIN; COPPER; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RESISTANCE; CANCER SURVIVAL; CELL LABELING; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE MARKER; DRUG EFFECT; DRUG INDICATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 12244249162     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(02)00038-6     Document Type: Article

References (23)

1. Wingo P.A., Tong T., Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 45(1):1995;8-30.
2. Riordan J.R., Deuchars K., Kartner N., Alon N., Trent J., Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature. 316(6031):1985;817-819.
3. Scheffer G.L., Wijngaard P.L., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M.et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1(6):1995;578-582.
4. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human "MDR1″ gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 84(9):1987;3004-3008.
5. Cole S.P., Sparks K.E., Fraser K., Loe D.W., Grant C.E., Wilson G.M. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54(22):1994;5902-5910.
6. Goldstein L.J., Galski H., Fojo A., Willingham M., Lai S.L., Gazdar A.et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 81(2):1989;116-124.
7. Nooter K., Bosman F.T., Burger H., van Wingerden K.E., Flens M.J., Scheper R.J.et al. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol. 7(1):1996;75-81.
8. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B.et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59(1):1999;8-13.
9. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58(23):1998;5337-5339.
10. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K.et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA. 95(26):1998;15665-15670.
11. Allen J.D., Brinkhuis R.F., Wijnholds J., Schinkel A.H. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res. 59(17):1999;4237-4241.
12. Volk E.L., Rohde K., Rhee M., McGuire J.J., Doyle L.A., Ross D.D.et al. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Res. 60(13):2000;3514-3521.
13. Bull P.C., Cox D.W. Wilson disease and Menkes disease: new handles on heavy-metal transport. Trends Genet. 10(7):1994;246-252.
14. Harris E.D., Qian Y., Tiffany-Castiglioni E., Lacy A.R., Reddy M.C. Functional analysis of copper homeostasis in cell culture models: a new perspective on internal copper transport. Am. J. Clin. Nutr. 67(5 Suppl):1998;988S-995S.
15. Petrukhin K., Lutsenko S., Chernov I., Ross B.M., Kaplan J.H., Gilliam T.C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet. 3(9):1994;1647-1656.
16. Terada K., Schilsky M.L., Miura N., Sugiyama T. ATP7B (WND) protein. Int J Biochem Cell Biol. 30(10):1998;1063-1067.
17. Solioz M., Vulpe C. CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem Sci. 21(7):1996;237-241.
18. Gupta A., Matsui K., Lo J.F., Silver S. Molecular basis for resistance to silver cations in Salmonella. Nat Med. 5(2):1999;183-188.
19. Komatsu M., Sumizawa T., Mutoh M., Chen Z.S., Terada K., Furukawa T.et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 60(5):2000;1312-1316.
20. Yang X.L., Miura N., Kawarada Y., Terada K., Petrukhin K., Gilliam T.et al. Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments. Biochem. J. 326(Pt 3):1997;897-902.
21. Bieche I., Lidereau R. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Mol Carcinog. 29(3):2000;151-158.
22. Eiriksdottir G., Johannesdottir G., Ingvarsson S., Bjornsdottir I.B., Jonasson J.G., Agnarsson B.A.et al. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer. 34(13):1998;2076-2081.
23. van den Berg J., Johannsson O., Hakansson S., Olsson H., Borg A. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer. 74(10):1996;1615-1619.